Select your timezone:
Reset
Sat
Sep 10 Sun
Sep 11 Mon
Sep 12 Tue
Sep 13 Wed
Sep 14 E-Posters
Time Room Session

08:00 - 09:30 |  State-of-the-Art and Workshop Sessions

08:00
- 09:30 		C1 View Oral Abstracts Session: Donation practices and public policy
Full Details
Alexander M Capron, United States
The “Global Kidney Exchange” proposal is impractical and not financially neutral
Alexander M Capron, United States
The “Global Kidney Exchange” proposal is impractical and not financially neutral
Jacqueline M Giuffrida, United States
One organ procurement organization's effective strategy for dramatically increasing donation after circulator death donation and transplantation
Jacqueline M Giuffrida, United States
One organ procurement organization's effective strategy for dramatically increasing donation after circulator death donation and transplantation
Amanda Vinson, Canada
Deceased Kidney Donor Acceptance Criteria: A Survey of Canadian Transplant Nephrologists, Surgeons and Urologists
Amanda Vinson, Canada
Deceased Kidney Donor Acceptance Criteria: A Survey of Canadian Transplant Nephrologists, Surgeons and Urologists
Tanveen Ishaque, United States
Outcomes After Declining a Donation after Cardiac Death (DCD) Liver for Transplant Candidates in the United States
Tanveen Ishaque, United States
Outcomes After Declining a Donation after Cardiac Death (DCD) Liver for Transplant Candidates in the United States
Lawrence Suplee, United States
OPTN kidney allocation policy change impact on OPO resource allocation
Lawrence Suplee, United States
OPTN kidney allocation policy change impact on OPO resource allocation
Jeffrey P Orlowski, United States
A Decade of Growth: One OPO’s Journey to Excellence
Jeffrey P Orlowski, United States
A Decade of Growth: One OPO’s Journey to Excellence
Alexander M Capron, United States
Family voucher programs: an ethical way to increase non-directed kidney donation
Alexander M Capron, United States
Family voucher programs: an ethical way to increase non-directed kidney donation
Wenshi Jiang, People's Republic of China
The first independent provincial OPO in China: Shanxi experience
Wenshi Jiang, People's Republic of China
The first independent provincial OPO in China: Shanxi experience
Simone Khouzam, United States
Global Kidney Exchange: Framework, Simulation, and Ethics for a Pilot Program
Simone Khouzam, United States
Global Kidney Exchange: Framework, Simulation, and Ethics for a Pilot Program
08:00
- 09:30 		C2 View Oral Abstracts Session: Kidney - Diagnostics 2
Full Details
Hatem Ali, United Kingdom
Prediction of graft survival among living kidney transplants in the tacrolimus/MMF era- an artificial intelligence approach
Hatem Ali, United Kingdom
Prediction of graft survival among living kidney transplants in the tacrolimus/MMF era- an artificial intelligence approach
Aravind Cherukuri, United States
Microvascular Inflammation in Renal Transplant Recipients Without Antibody Mediated Rejectiion
Aravind Cherukuri, United States
Microvascular Inflammation in Renal Transplant Recipients Without Antibody Mediated Rejectiion
Soufian Meziyerh, Netherlands
Development of high-performing and multicenter-validated dynamic prediction models with longitudinal measurements of serum creatinine and proteinuria for death-censored kidney graft failure
Soufian Meziyerh, Netherlands
Development of high-performing and multicenter-validated dynamic prediction models with longitudinal measurements of serum creatinine and proteinuria for death-censored kidney graft failure
Osama Ashry Gheith, Egypt
Inhibition of proprotein convertase subtilisin/Kexin type A (PCSK-9) among renal transplant recipients: is it beneficial for cases with high cardiovascular risk?
Osama Ashry Gheith, Egypt
Inhibition of proprotein convertase subtilisin/Kexin type A (PCSK-9) among renal transplant recipients: is it beneficial for cases with high cardiovascular risk?
Jennifer McDaniels, United States
Combined genome wide and single nuclei transcriptomics in posttransplant acute kidney injury identifies early proinflammatory/profibrogenic cell origin
Jennifer McDaniels, United States
Combined genome wide and single nuclei transcriptomics in posttransplant acute kidney injury identifies early proinflammatory/profibrogenic cell origin
Tara Sigdel, United States
Circulating plasma proteomics analysis of CMV infection in kidney transplantation
Tara Sigdel, United States
Circulating plasma proteomics analysis of CMV infection in kidney transplantation
Sandeep Sunildutt Singhal, India
Non-invasive assessment of renal allograft fibrosis by shearwave elastography: A radiological – pathological correlation analysis.
Sandeep Sunildutt Singhal, India
Non-invasive assessment of renal allograft fibrosis by shearwave elastography: A radiological – pathological correlation analysis.
William Lemieux, Canada
Dissecting the impact of molecular T-cell HLA mismatches in kidney graft failure: A retrospective cohort study
William Lemieux, Canada
Dissecting the impact of molecular T-cell HLA mismatches in kidney graft failure: A retrospective cohort study
Carlos Rubio Chacón, Spain
Capnometry values are a renal transplant evolution predictor in uncontrolled cardiac arrest death donors
Carlos Rubio Chacón, Spain
Capnometry values are a renal transplant evolution predictor in uncontrolled cardiac arrest death donors
08:00
- 09:30 		C3 View Workshop Session: Expanding the donor pool
Full Details
Lucas McCormack, Argentina
Transplanting expanded criteria donor livers
Lucas McCormack, Argentina
Transplanting expanded criteria donor livers
Wojciech Polak, Netherlands
How to assess suitability of the liver during organ recovery: the eye of the surgeon vs the microscope
Wojciech Polak, Netherlands
How to assess suitability of the liver during organ recovery: the eye of the surgeon vs the microscope
Christina Schleicher, Germany
How to assess suitability of the liver during organ recovery: the eye of the surgeon vs the microscope
Christina Schleicher, Germany
How to assess suitability of the liver during organ recovery: the eye of the surgeon vs the microscope
Markus Selzner, Canada
Current role of machine perfusion to increase liver utilization
Markus Selzner, Canada
Current role of machine perfusion to increase liver utilization
08:00
- 09:30 		C4 View Workshop Session: Updates on post-transplant infections, prevention and optimization (all organs)
Full Details
Camille N. Kotton, United States
Donor derived infections
Camille N. Kotton, United States
Donor derived infections
Maristela Pinheiro Freire, Brazil
How to manage pre and post transplant MDRO
Maristela Pinheiro Freire, Brazil
How to manage pre and post transplant MDRO
Atul Humar, Canada
CMV - what's hot, what's new?
Atul Humar, Canada
CMV - what's hot, what's new?
Hans H. Hirsch, Switzerland
New BKV guidelines
Hans H. Hirsch, Switzerland
New BKV guidelines
08:00
- 09:30 		C5 View Oral Abstracts Session: Immune regulation and tolerance 2
Full Details
Elmar Jaeckel, Canada
Membrane-bound IL-2 improves expansion, survival, phenotype and function of CAR Tregs and confers resistance to calcineurin-inhibitors
Elmar Jaeckel, Canada
Membrane-bound IL-2 improves expansion, survival, phenotype and function of CAR Tregs and confers resistance to calcineurin-inhibitors
Takayuki Hirose, United States
Successful induction of hematopoietic chimerism by dual inhibition of MCL-1 and Bcl-2 without myeloablative treatments in nonhuman primates
Takayuki Hirose, United States
Successful induction of hematopoietic chimerism by dual inhibition of MCL-1 and Bcl-2 without myeloablative treatments in nonhuman primates
Marie Sion, United Kingdom
Investigating iron limitation in tolerance and regulatory T cells' dynamic iron requirements
Marie Sion, United Kingdom
Investigating iron limitation in tolerance and regulatory T cells' dynamic iron requirements
Céline Sérazin, France
Expression of TNFR2 and CD29 define a highly suppressive subset of human CD8+ T regulatory cells
Céline Sérazin, France
Expression of TNFR2 and CD29 define a highly suppressive subset of human CD8+ T regulatory cells
Michael Nicosia, United States
The role of LAG3 in antibody responses to kidney transplantation
Michael Nicosia, United States
The role of LAG3 in antibody responses to kidney transplantation
Chiyoshi Toyama, Japan
The suppression of macrophage-mediated intestinal transplant rejection by C5a receptor antagonist
Chiyoshi Toyama, Japan
The suppression of macrophage-mediated intestinal transplant rejection by C5a receptor antagonist
Xiaoyan Huang, People's Republic of China
Study on the regulatory effect of iPS-derived exosomes on the local immune microenvironment in DCD kidney transplanted rats
Xiaoyan Huang, People's Republic of China
Study on the regulatory effect of iPS-derived exosomes on the local immune microenvironment in DCD kidney transplanted rats
Xiaoyan Huang, People's Republic of China
The role and mechanism of IFN-γ-UC-MSCs-PEG2 regulating MDSC hypermethylation and inducing immune tolerance in DCD kidney transplantation
Xiaoyan Huang, People's Republic of China
The role and mechanism of IFN-γ-UC-MSCs-PEG2 regulating MDSC hypermethylation and inducing immune tolerance in DCD kidney transplantation
08:00
- 09:30 		D View Workshop Session: Barriers to clinical application
Full Details
Alfred Joseph Tector, United States
Getting closer: an update on xenotransplantation
Alfred Joseph Tector, United States
Getting closer: an update on xenotransplantation
Robert Montgomery, United States
Ethical challenges in the development of models for clinical xenotransplantation
Robert Montgomery, United States
Ethical challenges in the development of models for clinical xenotransplantation
Jay A. Fishman, United States
Viral infections in xenotransplantation
Jay A. Fishman, United States
Viral infections in xenotransplantation
08:00
- 09:30 		E View Workshop Session: Prevention and management of donor-transmitted cancer after SOT
Full Details
Marieke Van Rosmalen, Netherlands
Donor with medical history of cancer
Marieke Van Rosmalen, Netherlands
Donor with medical history of cancer
Nazia Selzner, Canada
Deceased donor with recent finding of cancer
Nazia Selzner, Canada
Deceased donor with recent finding of cancer
Manuel Mendizabal, Argentina
Ethical aspects for the recipient
Manuel Mendizabal, Argentina
Ethical aspects for the recipient
08:00
- 09:30 		F View Oral Abstracts Session: Intestinal rehabilitation and transplant reports
Full Details
Francisco Hernandez, Spain
Experimental assay of intestinal graft viability and function after regional abdominal normothermic perfusion
Francisco Hernandez, Spain
Experimental assay of intestinal graft viability and function after regional abdominal normothermic perfusion
Maria Virginia Gentilini, Argentina
Successful pregnancy in a small bowel syndrome patient without any nutritional support. Case report: GLP-2 levels in pregnancy and breastfeeding
Maria Virginia Gentilini, Argentina
Successful pregnancy in a small bowel syndrome patient without any nutritional support. Case report: GLP-2 levels in pregnancy and breastfeeding
Hector Solar, Argentina
Chronic intestinal failure due to short bowel syndrome in adult patients: 15 years of experience in intestinal rehabilitation at a referral center in Argentina
Hector Solar, Argentina
Chronic intestinal failure due to short bowel syndrome in adult patients: 15 years of experience in intestinal rehabilitation at a referral center in Argentina
Maria Florencia Fernandez, Argentina
Mortality on the waiting list for pediatric patients requiring liver containing intestinal grafts in Argentina, how can we reverse the lack of donors?
Maria Florencia Fernandez, Argentina
Mortality on the waiting list for pediatric patients requiring liver containing intestinal grafts in Argentina, how can we reverse the lack of donors?
Carolina Rumbo, Argentina
Long term results on intestinal rehabilitation of children treated at a single multidisciplinary unit
Carolina Rumbo, Argentina
Long term results on intestinal rehabilitation of children treated at a single multidisciplinary unit
Carolyn Smullin, United States
Noninvasive biomarkers for allograft monitoring after intestinal transplantation: promising early results from a novel peptide, REG3α
Carolyn Smullin, United States
Noninvasive biomarkers for allograft monitoring after intestinal transplantation: promising early results from a novel peptide, REG3α
Emilio Canovai, United Kingdom
Preventing encephalopathy after isolated small bowel transplantation through portal graft drainage
Emilio Canovai, United Kingdom
Preventing encephalopathy after isolated small bowel transplantation through portal graft drainage
Emilio Canovai, United Kingdom
Treatment of complex Desmoid tumours by Intestinal Transplantation
Emilio Canovai, United Kingdom
Treatment of complex Desmoid tumours by Intestinal Transplantation

09:40 - 11:40 |  President's Plenary Session

09:40
- 11:40 		A View President's plenary & awards
Full Details

11:40 - 12:00 |  Coffee Break | Exhibit | Poster Viewing

11:40 - 12:00 |  Expo Studio Session

12:00 - 13:00 |  Oral and Mini-Oral Abstract Sessions

12:00
- 13:00 		C1 View Oral Abstracts Session: COVID-19 - Outcomes
Full Details
Sanshriti Chauhan, India
Comparative analysis of kidney transplant recipients with SARS-CoV-2 compared with non-kidney transplant recipients: A largest single center report from the second wave of COVID-19 pandemic in South East Asia.
Sanshriti Chauhan, India
Comparative analysis of kidney transplant recipients with SARS-CoV-2 compared with non-kidney transplant recipients: A largest single center report from the second wave of COVID-19 pandemic in South East Asia.
Sanshriti Chauhan, India
Outcomes of living donor kidney transplantation after SARS-CoV-2 infection in both the donor and the recipient: A multicenter study Running title: LDKT in COVID-19 survivors
Sanshriti Chauhan, India
Outcomes of living donor kidney transplantation after SARS-CoV-2 infection in both the donor and the recipient: A multicenter study Running title: LDKT in COVID-19 survivors
Allan B Massie, United States
Quantifying Excess Deaths Among Solid Organ Transplant Recipients in the COVID-19 Era
Allan B Massie, United States
Quantifying Excess Deaths Among Solid Organ Transplant Recipients in the COVID-19 Era
Christian Unterrainer, Germany
Diagnosis of SARS-CoV-2 Infection and Impact on Subsequent 1-year Patient Survival in Kidney Transplant Recipients – A report of the Collaborative Transplant Study
Christian Unterrainer, Germany
Diagnosis of SARS-CoV-2 Infection and Impact on Subsequent 1-year Patient Survival in Kidney Transplant Recipients – A report of the Collaborative Transplant Study
Monica Nakamura, Brazil
The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study
Monica Nakamura, Brazil
The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study
Terence Kee, Singapore
Impact of COVID-19 era, nation's economic status, vaccination status, vaccine doses and new COVID-19 therapeutics on mortality from COVID-19 infections in kidney transplant recipients from Asia: An Asian Society of Transplantation Research Group (ASTREGO) Analysis
Terence Kee, Singapore
Impact of COVID-19 era, nation's economic status, vaccination status, vaccine doses and new COVID-19 therapeutics on mortality from COVID-19 infections in kidney transplant recipients from Asia: An Asian Society of Transplantation Research Group (ASTREGO) Analysis
12:00
- 13:00 		C2 View Oral Abstracts Session: Basic and translational investigation/ combined liver-kidney transplantation
Full Details
Samy M Riad, United States
Crossmatch positive status does not impact long term outcomes in simultaneous liver kidney transplants
Samy M Riad, United States
Crossmatch positive status does not impact long term outcomes in simultaneous liver kidney transplants
Hillary Braun, United States
Rejection after liver transplantation: what can we learn from transcriptomic analysis?
Hillary Braun, United States
Rejection after liver transplantation: what can we learn from transcriptomic analysis?
Ignacio E Roca, Argentina
Preoperative Cystatin C predicts acute kidney injury following liver transplantation in patients with normal serum creatinine
Ignacio E Roca, Argentina
Preoperative Cystatin C predicts acute kidney injury following liver transplantation in patients with normal serum creatinine
Thomas V Rousselle, United States
Molecular Characterization of Progressive Fibrosis in The Liver by Single-nuclei RNA Sequencing
Thomas V Rousselle, United States
Molecular Characterization of Progressive Fibrosis in The Liver by Single-nuclei RNA Sequencing
Yang Bai, People's Republic of China
Autophagy mediates liver functional recovery from donation after circulatory death rats with normothermic machine perfusion
Yang Bai, People's Republic of China
Autophagy mediates liver functional recovery from donation after circulatory death rats with normothermic machine perfusion
Kenji Okumura, United States
Inferior long-term outcomes of simultaneous liver-kidney transplantation using donation after cardiac deaths donors in the United Network for Organ Sharing database
Kenji Okumura, United States
Inferior long-term outcomes of simultaneous liver-kidney transplantation using donation after cardiac deaths donors in the United Network for Organ Sharing database
12:00
- 13:00 		C3 View Mini-Oral Abstracts Session: Kidney - Outcomes 2
Full Details
Paulo S da Silva Santos, Brazil
Lip actinic cheilitis and its relationship to clinical characteristics and immunosuppression in kidney transplant recipients
Paulo S da Silva Santos, Brazil
Lip actinic cheilitis and its relationship to clinical characteristics and immunosuppression in kidney transplant recipients
Lucino Bahena Carrera, Mexico
High intrapatient variability tacrolimus´s levels is associated with post-transplant diabetes mellitus in kidney transplant, a Mexican cohort
Lucino Bahena Carrera, Mexico
High intrapatient variability tacrolimus´s levels is associated with post-transplant diabetes mellitus in kidney transplant, a Mexican cohort
Lúcio Requião-Moura, Brazil
The performance of the Kidney Donor Profile Index in predicting outcomes for Brazilian kidney transplant recipients of standard criteria donors.
Lúcio Requião-Moura, Brazil
The performance of the Kidney Donor Profile Index in predicting outcomes for Brazilian kidney transplant recipients of standard criteria donors.
Daan Kremer, Netherlands
Effect of vitamin K2-supplementation on calcification propensity and vascular stiffness in vitamin K-deficient kidney transplant recipients: a randomized, double-blind, placebo-controlled clinical trial
Daan Kremer, Netherlands
Effect of vitamin K2-supplementation on calcification propensity and vascular stiffness in vitamin K-deficient kidney transplant recipients: a randomized, double-blind, placebo-controlled clinical trial
Daan Kremer, Netherlands
Poor Sleep Quality, Fatigue, Social Participation and Health-Related Quality of Life in Kidney Transplant Recipients
Daan Kremer, Netherlands
Poor Sleep Quality, Fatigue, Social Participation and Health-Related Quality of Life in Kidney Transplant Recipients
Fernanda G Rodrigues, Netherlands
Pre-Transplant Hyperparathyroidism and Adverse Post-Transplant Outcomes in Kidney Transplant Recipients
Fernanda G Rodrigues, Netherlands
Pre-Transplant Hyperparathyroidism and Adverse Post-Transplant Outcomes in Kidney Transplant Recipients
Tim J Knobbe, Netherlands
Proton-Pump Inhibitor Use, Fatigue and Health-Related Quality of Life in Kidney Transplant Recipients
Tim J Knobbe, Netherlands
Proton-Pump Inhibitor Use, Fatigue and Health-Related Quality of Life in Kidney Transplant Recipients
Tarek S. H. Mahmoud, Kuwait
Outcomes of sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in diabetic kidney transplant recipients
Tarek S. H. Mahmoud, Kuwait
Outcomes of sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in diabetic kidney transplant recipients
Mahmoud Mohamed, United States
Association of Skin Cancer with the use of Azathioprine and Mycophenolate mofetil in Kidney Transplant Recipients
Mahmoud Mohamed, United States
Association of Skin Cancer with the use of Azathioprine and Mycophenolate mofetil in Kidney Transplant Recipients
Xiaoqian Ma, People's Republic of China
Blocking of the CD40-CD154 pathway inhibits macrophage infiltration and reduces fibrosis after renal transplantation
Xiaoqian Ma, People's Republic of China
Blocking of the CD40-CD154 pathway inhibits macrophage infiltration and reduces fibrosis after renal transplantation
Yunyoung Jang, Korea
New-onset osteoporotic fracture after kidney transplantation: a matched comparative nationwide cohort study
Yunyoung Jang, Korea
New-onset osteoporotic fracture after kidney transplantation: a matched comparative nationwide cohort study
Kyong Ihn, Korea
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation: a nationwide cohort study in Korea
Kyong Ihn, Korea
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation: a nationwide cohort study in Korea
12:00
- 13:00 		C4 View Mini-Oral Abstracts Session: Organ tissue donation
Full Details
Samrat Ray, Canada
Donation after Cardiac Death (DCD) liver grafts from elderly donors: a comparative analysis of feasibility and outcome
Samrat Ray, Canada
Donation after Cardiac Death (DCD) liver grafts from elderly donors: a comparative analysis of feasibility and outcome
John Gill, Canada
Towards a national system of living donor follow-up in Canada
John Gill, Canada
Towards a national system of living donor follow-up in Canada
Manuel Rodriguez-Davalos, United States
How Whole Slide Imaging and AI Can Improve Organ Transplants
Manuel Rodriguez-Davalos, United States
How Whole Slide Imaging and AI Can Improve Organ Transplants
Angus Hann, United Kingdom
Normothermic machine perfusion compared with static cold storage of liver grafts for late liver retransplantation: Results of the NAPLES initiative
Angus Hann, United Kingdom
Normothermic machine perfusion compared with static cold storage of liver grafts for late liver retransplantation: Results of the NAPLES initiative
María M Granados Madero, Spain
Controlled asystole donation in patients older than 70 years old- it is really worth it?
María M Granados Madero, Spain
Controlled asystole donation in patients older than 70 years old- it is really worth it?
Amina R Silva, Canada
Organ Donation Following Medical Assistance in Dying: A Scoping Review
Amina R Silva, Canada
Organ Donation Following Medical Assistance in Dying: A Scoping Review
Martha S Perez Cornejo, Mexico
A model for increasing organ and tissue donation: the social service in medicine
Martha S Perez Cornejo, Mexico
A model for increasing organ and tissue donation: the social service in medicine
Emmanouil Giorgakis, United States
The Impact of UNOS Acuity Circles-Based Organ Allocation on DCD Liver Transplant Rates and Waitlist Mortality in the United States
Emmanouil Giorgakis, United States
The Impact of UNOS Acuity Circles-Based Organ Allocation on DCD Liver Transplant Rates and Waitlist Mortality in the United States
Seyed Ali Malek Hosseini, Iran (Islamic Republic of)
The beginning of the end for living unrelated donation kidney transplantations in the Middle East: the Shiraz Transplant Center experience
Seyed Ali Malek Hosseini, Iran (Islamic Republic of)
The beginning of the end for living unrelated donation kidney transplantations in the Middle East: the Shiraz Transplant Center experience
Jessica M Ruck, United States
HCV-Viremic Donor Allograft Consideration by Organ Type and Year, among Adult and Pediatric Solid Organ Transplant Candidates
Jessica M Ruck, United States
HCV-Viremic Donor Allograft Consideration by Organ Type and Year, among Adult and Pediatric Solid Organ Transplant Candidates
Yajie Ma, People's Republic of China
Summarizing the characteristics of the recent progress of organ donation and transplantation in China by using GODT data
Yajie Ma, People's Republic of China
Summarizing the characteristics of the recent progress of organ donation and transplantation in China by using GODT data
12:00
- 13:00 		C5 View Mini-Oral Abstracts Session: Xenotransplantation
Full Details
Grace Lassiter, United States
Long-term (>1 year) rejection/TMA free survival of kidney xenografts with triple xenoantigen knockout and multiple human transgenes in nonhuman primates
Grace Lassiter, United States
Long-term (>1 year) rejection/TMA free survival of kidney xenografts with triple xenoantigen knockout and multiple human transgenes in nonhuman primates
Alexandre Loupy, France
Histological And Molecular Characterization Of Kidney Xenografts Transplanted To Decedent Humans
Alexandre Loupy, France
Histological And Molecular Characterization Of Kidney Xenografts Transplanted To Decedent Humans
Wayne Hawthorne, Australia
Review of the safety and efficacy of immunosuppression in the pig-to-nonhuman primate islet xenotransplantation model
Wayne Hawthorne, Australia
Review of the safety and efficacy of immunosuppression in the pig-to-nonhuman primate islet xenotransplantation model
Paolo Brenner, Germany
The perioperative cardiac xenograft dysfunction (PCXD) has a major impact in (life-supporting) orthotopic (oXTx) cardiac xenotransplantation, but not in the heterotopic thoracic (htXTx) xenotransplantation.
Paolo Brenner, Germany
The perioperative cardiac xenograft dysfunction (PCXD) has a major impact in (life-supporting) orthotopic (oXTx) cardiac xenotransplantation, but not in the heterotopic thoracic (htXTx) xenotransplantation.
Arthur A Cross-Najafi, United States
The role of co-expressing MHC class I molecules in pig endothelial cells: a case for HLA-E and HLA-G in xenotransplantation
Arthur A Cross-Najafi, United States
The role of co-expressing MHC class I molecules in pig endothelial cells: a case for HLA-E and HLA-G in xenotransplantation
Ryan Chaban, United States
Complement pathway regulatory protein genotype is associated with delayed kinetics of GTKO lung xenograft injury
Ryan Chaban, United States
Complement pathway regulatory protein genotype is associated with delayed kinetics of GTKO lung xenograft injury
Ryan Chaban, United States
Patient selection for pig cardiac xenotransplantation
Ryan Chaban, United States
Patient selection for pig cardiac xenotransplantation
Kevin J Lopez, United States
Porcine ULBP1 disruption does not significantly reduce human NK cell activation and cytotoxicity in an in vitro model
Kevin J Lopez, United States
Porcine ULBP1 disruption does not significantly reduce human NK cell activation and cytotoxicity in an in vitro model
Haina Wang, Australia
Shared transcriptional trajectory of tissue tregs between tolerant-grafts and lymphoid organs in transplant tolerance
Haina Wang, Australia
Shared transcriptional trajectory of tissue tregs between tolerant-grafts and lymphoid organs in transplant tolerance
Jeffrey M Stern, United States
Cytokine Analysis of First Gal-KO Renal Xenotransplantation from a Pig-to-Human Recipient
Jeffrey M Stern, United States
Cytokine Analysis of First Gal-KO Renal Xenotransplantation from a Pig-to-Human Recipient
Zahra A Habibabady, United States
Cross-reacting antibodies in xenotransplantation
Zahra A Habibabady, United States
Cross-reacting antibodies in xenotransplantation
Martina Raneri, Australia
Potent suppressive function of xeno-antigen reactive human HLADR+CD27+Tregs via enhanced CD95 and ICOS expressions
Martina Raneri, Australia
Potent suppressive function of xeno-antigen reactive human HLADR+CD27+Tregs via enhanced CD95 and ICOS expressions
12:00
- 13:00 		D View Oral Abstracts Session: Ischemia/reperfusion injury 1
Full Details
Gannon McGrath, United States
Ischemia minimization improves cardiac function in an ex vivo xeno working heart model
Gannon McGrath, United States
Ischemia minimization improves cardiac function in an ex vivo xeno working heart model
John Black, United Kingdom
A proof of principle study of cell targeted delivery of siRNA guided by innate repair receptor EPOR/betacR highly expressed by injured tubular epithelial cells in porcine kidneys subjected to extended cold ischaemic times
John Black, United Kingdom
A proof of principle study of cell targeted delivery of siRNA guided by innate repair receptor EPOR/betacR highly expressed by injured tubular epithelial cells in porcine kidneys subjected to extended cold ischaemic times
Luke VanOsdol, United States
Exploring cell-specific mechanisms of ischemia/reperfusion injury mediated reactivation of cytomegalovirus from latency in the orthotopic mouse lung transplantation
Luke VanOsdol, United States
Exploring cell-specific mechanisms of ischemia/reperfusion injury mediated reactivation of cytomegalovirus from latency in the orthotopic mouse lung transplantation
Jiang Liu, People's Republic of China
PGC1alpha-mediated metabolic reprogramming facilitates M1 macrophage polarization during steatotic allograft dysfunction after liver transplantation
Jiang Liu, People's Republic of China
PGC1alpha-mediated metabolic reprogramming facilitates M1 macrophage polarization during steatotic allograft dysfunction after liver transplantation
Alireza Biglarnia, Sweden
TUM012 – a new polymer for ex vivo allograft coating to minimize post-reperfusion thromboinflammation in kidney transplantation
Alireza Biglarnia, Sweden
TUM012 – a new polymer for ex vivo allograft coating to minimize post-reperfusion thromboinflammation in kidney transplantation
Masataka Kawamura, Canada
AP39 administration during normothermic ex vivo kidney perfusion reduces preservation injury
Masataka Kawamura, Canada
AP39 administration during normothermic ex vivo kidney perfusion reduces preservation injury
12:00
- 13:00 		E View Oral Abstracts Session: HLA-DSA
Full Details
Hatem Ali, United Kingdom
Prediction of graft survival among deceased transplants: An AI approach
Hatem Ali, United Kingdom
Prediction of graft survival among deceased transplants: An AI approach
Jennifer D Motter, Canada
Early Clinical Complications Following HLA-incompatible Living Donor Kidney Transplantation
Jennifer D Motter, Canada
Early Clinical Complications Following HLA-incompatible Living Donor Kidney Transplantation
Juliana O Martins, Brazil
ANTI-HNA-3 antibodies in kidney transplant rejection: is it an immunological risk factor?
Juliana O Martins, Brazil
ANTI-HNA-3 antibodies in kidney transplant rejection: is it an immunological risk factor?
Sara Sanz-Ureña, Spain
Pregnancy-induced sensitization in female transplant candidates: HLA-specific memory B cells and paternal HLA epitope mismatch
Sara Sanz-Ureña, Spain
Pregnancy-induced sensitization in female transplant candidates: HLA-specific memory B cells and paternal HLA epitope mismatch
Kristoffer Ted M Angala, Philippines
Impact of HLA-DQ mismatch on renal transplant outcomes: A single-center retrospective cohort study
Kristoffer Ted M Angala, Philippines
Impact of HLA-DQ mismatch on renal transplant outcomes: A single-center retrospective cohort study
12:00
- 13:00 		F View Mini-Oral Abstracts Session: Pediatric Transplantation
Full Details
Felicia Kjaernet, Sweden
Equal outcome and fewer complications with azathioprine compared to mycophenolate in pediatric first-time kidney transplantation: should current practice be re-evaluated?
Felicia Kjaernet, Sweden
Equal outcome and fewer complications with azathioprine compared to mycophenolate in pediatric first-time kidney transplantation: should current practice be re-evaluated?
Maria Julia Minetto, Argentina
Results of 922 pediatric liver transplants: prognostic factors, learning curve and impact on one-year survival.
Maria Julia Minetto, Argentina
Results of 922 pediatric liver transplants: prognostic factors, learning curve and impact on one-year survival.
Dario N Teran, Argentina
Pediatric liver transplantation: Twenty-five-year experience at a single center
Dario N Teran, Argentina
Pediatric liver transplantation: Twenty-five-year experience at a single center
Olga Gichkun, Russian Federation
Plasma level of TGF beta 1 is associated with the polymorphism rs1800469 of the TGFB1 gene in pediatric liver recipients
Olga Gichkun, Russian Federation
Plasma level of TGF beta 1 is associated with the polymorphism rs1800469 of the TGFB1 gene in pediatric liver recipients
Alexandru Emil Baetu, Romania
One year survival comparison of deceased donor versus living donor hepatic pediatric transplantation. Meta-analysis
Alexandru Emil Baetu, Romania
One year survival comparison of deceased donor versus living donor hepatic pediatric transplantation. Meta-analysis
Paulo C. Koch Nogueira, Brazil
Long-term results of kidney transplantation in children with bodyweight lower than 10 Kg.
Paulo C. Koch Nogueira, Brazil
Long-term results of kidney transplantation in children with bodyweight lower than 10 Kg.
Qiang Zhang, People's Republic of China
Outcomes of single kidney transplantation from pediatric donors with acute kidney injury into pediatric recipients
Qiang Zhang, People's Republic of China
Outcomes of single kidney transplantation from pediatric donors with acute kidney injury into pediatric recipients
Ashwin J Bhana, Australia
ABO-incompatible Liver Transplantation Is A Safe And Effective Intervention For Paediatric Recipients
Ashwin J Bhana, Australia
ABO-incompatible Liver Transplantation Is A Safe And Effective Intervention For Paediatric Recipients
Loes Oomen, Netherlands
A pre-transplant risk assessment tool for outcome in pediatric kidney transplantation based on a Dutch cohort of 1415 patients
Loes Oomen, Netherlands
A pre-transplant risk assessment tool for outcome in pediatric kidney transplantation based on a Dutch cohort of 1415 patients
Thomas Nakagawa, United States
The Impact of COVID-19 on Pediatric Organ Donation and Transplantation
Thomas Nakagawa, United States
The Impact of COVID-19 on Pediatric Organ Donation and Transplantation
Olga Caporale, Italy
Influence of migration status on practice and clinical course of pediatric kidney transplantation
Olga Caporale, Italy
Influence of migration status on practice and clinical course of pediatric kidney transplantation
Meraj Alam Siddiqui, Turkey
Eculizumab therapy for late antibody-mediated rejection in pediatric kidney transplant patients
Meraj Alam Siddiqui, Turkey
Eculizumab therapy for late antibody-mediated rejection in pediatric kidney transplant patients

13:00 - 14:25 |  Lunch Break Hall B

13:15 - 14:15 |  Lunch Symposium

14:25 - 15:25 |  Oral and Mini-Oral Sessions

14:25
- 15:25 		C1 View Oral Abstracts Session: COVID-19 - Transplant with positive donors, immunosuppression management
Full Details
Ines Ushiro-Lumb, United Kingdom
Successful transplantation from selected SARS-CoV-2 RNA positive deceased donors
Ines Ushiro-Lumb, United Kingdom
Successful transplantation from selected SARS-CoV-2 RNA positive deceased donors
Jorge Sanchez-Garcia, United States
Early experience of solid organs transplantation from COVID-19 positive donors in a single institute
Jorge Sanchez-Garcia, United States
Early experience of solid organs transplantation from COVID-19 positive donors in a single institute
Lúcio Requião-Moura, Brazil
The use of mTOR inhibitors is associated with reduced mortality among kidney transplant patients developing COVID-19.
Lúcio Requião-Moura, Brazil
The use of mTOR inhibitors is associated with reduced mortality among kidney transplant patients developing COVID-19.
Emilio Poggio, United States
Single center clinical outcomes of 112 kidney transplant recipients of SARS-CoV-2 positive and negative deceased donors
Emilio Poggio, United States
Single center clinical outcomes of 112 kidney transplant recipients of SARS-CoV-2 positive and negative deceased donors
Mahmoud Mohamed, United States
Safety of Accepting Kidneys From Deceased Kidney Donors Who Tested Positive For COVID-19 Virus
Mahmoud Mohamed, United States
Safety of Accepting Kidneys From Deceased Kidney Donors Who Tested Positive For COVID-19 Virus
Wasim Dar, United States
Transplantation of organs from SARS-CoV-2-positive donors to uninfected (non-lung) solid organ transplant recipients has not resulted in significant SARS-CoV-2 related morbidity or mortality
Wasim Dar, United States
Transplantation of organs from SARS-CoV-2-positive donors to uninfected (non-lung) solid organ transplant recipients has not resulted in significant SARS-CoV-2 related morbidity or mortality
14:25
- 15:25 		C2 View Oral Abstracts Session: Donor intend, identification, anesthesia and critical care
Full Details
Shannon M Kaminski, United States
Six scenarios that trigger organ donation conversations with NOK: one OPO’s experience
Shannon M Kaminski, United States
Six scenarios that trigger organ donation conversations with NOK: one OPO’s experience
Shannon M Kaminski, United States
One Organ Procurement Organization’s 26-year experience with uncontrolled DCD donation
Shannon M Kaminski, United States
One Organ Procurement Organization’s 26-year experience with uncontrolled DCD donation
Mihaela A Damian, United States
Evolution of thromboelastography parameters during Pediatric Liver transplantation
Mihaela A Damian, United States
Evolution of thromboelastography parameters during Pediatric Liver transplantation
Govind Rangrass, United States
Extracorporeal membrane oxygenation use in orthotopic liver transplantation as a viable bridge to transplant and tool for intraoperative and postoperative rescue
Govind Rangrass, United States
Extracorporeal membrane oxygenation use in orthotopic liver transplantation as a viable bridge to transplant and tool for intraoperative and postoperative rescue
Matthew Weiss, Canada
Rates of effective intent-to-donate in Nova Scotia: mitigation of differences by gender and age after enactment of deemed consent legislation
Matthew Weiss, Canada
Rates of effective intent-to-donate in Nova Scotia: mitigation of differences by gender and age after enactment of deemed consent legislation
14:25
- 15:25 		C3 View Mini-Oral Abstracts Session: Ischemia/reperfusion injury 2
Full Details
Turaab H Khan, Australia
Protection from the second warm ischemic injury in kidney transplantation using an ex vivo non-utilised human kidney model and thermally insulating jacket
Turaab H Khan, Australia
Protection from the second warm ischemic injury in kidney transplantation using an ex vivo non-utilised human kidney model and thermally insulating jacket
David W Mathes, United States
Investigating galectin-3 as a novel therapeutic target to block inflammation and reduce ischemia reperfusion injury during vascular composite allograft transplantation
David W Mathes, United States
Investigating galectin-3 as a novel therapeutic target to block inflammation and reduce ischemia reperfusion injury during vascular composite allograft transplantation
Marc Micó-Carnero, Spain
Using a new preservation solution called PERLA for kidney transplantation
Marc Micó-Carnero, Spain
Using a new preservation solution called PERLA for kidney transplantation
Aspasia Pefanis, Australia
Necroptosis plays a role in acute kidney injury (AKI) and the progression to renal fibrosis following ischemia reperfusion injury (IRI)
Aspasia Pefanis, Australia
Necroptosis plays a role in acute kidney injury (AKI) and the progression to renal fibrosis following ischemia reperfusion injury (IRI)
Gabriel Strandberg, Sweden
Instant post-reperfusion Thromboinflammation in Clinical Kidney Transplantation and its possible Impact on Outcome
Gabriel Strandberg, Sweden
Instant post-reperfusion Thromboinflammation in Clinical Kidney Transplantation and its possible Impact on Outcome
Jennifer Li, Australia
Adoptive tolerogenic dendritic cell therapy protects against renal ischemia reperfusion injury
Jennifer Li, Australia
Adoptive tolerogenic dendritic cell therapy protects against renal ischemia reperfusion injury
Mark Ly, Australia
How much is too much? Determining the optimal oxygen concentration for early hypothermic oxygenation of liver grafts in rodents
Mark Ly, Australia
How much is too much? Determining the optimal oxygen concentration for early hypothermic oxygenation of liver grafts in rodents
14:25
- 15:25 		C4 View Mini-Oral Abstracts Session: Kidney - Living donation
Full Details
Nisarg V Gandhi, United States
Characteristics and Long-Term Outcomes of Female Kidney Donors
Nisarg V Gandhi, United States
Characteristics and Long-Term Outcomes of Female Kidney Donors
Shivani S. Bisen, United States
Patient and graft survival after A1/A2-incompatible living donor kidney transplantation
Shivani S. Bisen, United States
Patient and graft survival after A1/A2-incompatible living donor kidney transplantation
Jennifer D Motter, Canada
Long-term outcomes following HLA-incompatible living donor kidney transplantation
Jennifer D Motter, Canada
Long-term outcomes following HLA-incompatible living donor kidney transplantation
Juliana Bastos, Brazil
KPD in STALYC countries
Juliana Bastos, Brazil
KPD in STALYC countries
Juliana Bastos, Brazil
Raising the potential of transplantation with a KPD collaborative program
Juliana Bastos, Brazil
Raising the potential of transplantation with a KPD collaborative program
Fernando H Margulis, Argentina
Salt sensitivity in living kidney donors: a new cardiovascular risk factor?
Fernando H Margulis, Argentina
Salt sensitivity in living kidney donors: a new cardiovascular risk factor?
Hari Shankar Meshram, India
Impact of single centre 440 kidney exchange transplantation over 20 years to increase living donor pool in India: a cohort study
Hari Shankar Meshram, India
Impact of single centre 440 kidney exchange transplantation over 20 years to increase living donor pool in India: a cohort study
Heidi Sarumi, United States
Live donated kidneys don't behave like the one left behind
Heidi Sarumi, United States
Live donated kidneys don't behave like the one left behind
Michael Rees, United States
The First 52 Global Kidney Exchange Transplants: overcoming multiple barriers to transplantation
Michael Rees, United States
The First 52 Global Kidney Exchange Transplants: overcoming multiple barriers to transplantation
Michael McCabe, United States
Mixed minimally invasive surgical modalities in living donor kidney transplant: outcomes and surgical complications
Michael McCabe, United States
Mixed minimally invasive surgical modalities in living donor kidney transplant: outcomes and surgical complications
Rolf Weimer, Germany
Long-term compromised immune regulation after rituximab induction in blood group incompatible living-donor renal transplantation - 5 year results of a prospective pilot study
Rolf Weimer, Germany
Long-term compromised immune regulation after rituximab induction in blood group incompatible living-donor renal transplantation - 5 year results of a prospective pilot study
Ekamol Tantisattamo, United States
Dietary protein intake and blood pressure after living kidney donation
Ekamol Tantisattamo, United States
Dietary protein intake and blood pressure after living kidney donation
14:25
- 15:25 		C5 View Mini-Oral Abstracts Session: Transplant infectious diseases 2
Full Details
Clarisse Machado, Brazil
Epidemiology of cytomegalovirus infection and disease in hematopoietic stem cell transplant recipients in selected countries outside of North America and Europe: A systematic review
Clarisse Machado, Brazil
Epidemiology of cytomegalovirus infection and disease in hematopoietic stem cell transplant recipients in selected countries outside of North America and Europe: A systematic review
Clarisse Machado, Brazil
Real-world treatment patterns and outcomes for cytomegalovirus infection and disease in hematopoietic stem cell transplant recipients in selected countries outside of North America and Europe: A systematic review
Clarisse Machado, Brazil
Real-world treatment patterns and outcomes for cytomegalovirus infection and disease in hematopoietic stem cell transplant recipients in selected countries outside of North America and Europe: A systematic review
Jose Otto Reusing Junior, Brazil
Prediction model with Quantiferon-CMV for clinically significant cytomegalovirus event in seropositive kidney transplant recipients
Jose Otto Reusing Junior, Brazil
Prediction model with Quantiferon-CMV for clinically significant cytomegalovirus event in seropositive kidney transplant recipients
John Friedewald, United States
Temporal and diversity characterization of metagenomic viral detection in kidney transplant recipients
John Friedewald, United States
Temporal and diversity characterization of metagenomic viral detection in kidney transplant recipients
Sunil Kumar Dodani, Pakistan
Trends of Antibiotic Resistance in E. coli, Klebsiella Spp., Pseudomonas aeruginosa and Enterococcus spp. Urinary Tract Infection in Renal Transplant Recipients from Pakistan over a Decade
Sunil Kumar Dodani, Pakistan
Trends of Antibiotic Resistance in E. coli, Klebsiella Spp., Pseudomonas aeruginosa and Enterococcus spp. Urinary Tract Infection in Renal Transplant Recipients from Pakistan over a Decade
Davide Abate, Italy
The protection from CMV infection in solid organ transplants is highly dependent on CMV T-cell specific immunity and type of organ transplant
Davide Abate, Italy
The protection from CMV infection in solid organ transplants is highly dependent on CMV T-cell specific immunity and type of organ transplant
Hayley A. Cleveland, United States
Renal Transplant Outcomes: Hepatitis C-infected Donors and Recipients
Hayley A. Cleveland, United States
Renal Transplant Outcomes: Hepatitis C-infected Donors and Recipients
Jose Manuel Arriola Guerra, Mexico
The screening and treatment of asymptomatic bacteriuria do not reduce the incidence of urinary tract infection or pyelonephritis in the first two months after renal transplantation. A randomized controlled trial.
Jose Manuel Arriola Guerra, Mexico
The screening and treatment of asymptomatic bacteriuria do not reduce the incidence of urinary tract infection or pyelonephritis in the first two months after renal transplantation. A randomized controlled trial.
Helio Tedesco Silva Jr, Brazil
Epidemiology of cytomegalovirus infection and disease in solid organ transplant recipients in selected countries outside of North America and Europe: A systematic review
Helio Tedesco Silva Jr, Brazil
Epidemiology of cytomegalovirus infection and disease in solid organ transplant recipients in selected countries outside of North America and Europe: A systematic review
Cai Jinzhen, People's Republic of China
Real-world treatment patterns and outcomes for cytomegalovirus infection and disease in solid organ transplant recipients in selected countries outside North America and Europe: A systematic review
Cai Jinzhen, People's Republic of China
Real-world treatment patterns and outcomes for cytomegalovirus infection and disease in solid organ transplant recipients in selected countries outside North America and Europe: A systematic review
Javier Carbone, Spain
A 5-dose IVIG protocol decreases the risk of reinfection in solid organ transplant patients with secondary antibody immunodeficiency: Results of a multicenter randomized clinical trial
Javier Carbone, Spain
A 5-dose IVIG protocol decreases the risk of reinfection in solid organ transplant patients with secondary antibody immunodeficiency: Results of a multicenter randomized clinical trial
Hope Werenski, United States
Donor-Derived Acute Hepatitis A Virus Infection in Two Kidney Transplant Recipients from a Common Donor
Hope Werenski, United States
Donor-Derived Acute Hepatitis A Virus Infection in Two Kidney Transplant Recipients from a Common Donor
Jing-Yi Liu, People's Republic of China
The diagnosis and treatment of posttransplant lymphoproliferative disorder in pediatric liver transplant recipients
Jing-Yi Liu, People's Republic of China
The diagnosis and treatment of posttransplant lymphoproliferative disorder in pediatric liver transplant recipients
14:25
- 15:25 		D View Oral Abstracts Session: Immunosuppression and cellular immunology
Full Details
Moumita Paul-Heng, Australia
Single Cell Alloreactive TCR Repertoire Profiling
Moumita Paul-Heng, Australia
Single Cell Alloreactive TCR Repertoire Profiling
Robert L. Fairchild, United States
Recipient Myeloid Cell Myeloperoxidase Is Required for NK cell Activation and Regulates Antibody-Mediated Acute vs. Chronic Kidney Allograft Rejection
Robert L. Fairchild, United States
Recipient Myeloid Cell Myeloperoxidase Is Required for NK cell Activation and Regulates Antibody-Mediated Acute vs. Chronic Kidney Allograft Rejection
Jianing Fu, United States
Single-Cell Immune Profiling of Human Intestinal Allografts Reveals Differential Phenotypes of Alloreactive T-cell Clones in Quiescent vs Chronically Rejecting Allografts
Jianing Fu, United States
Single-Cell Immune Profiling of Human Intestinal Allografts Reveals Differential Phenotypes of Alloreactive T-cell Clones in Quiescent vs Chronically Rejecting Allografts
Ibrahim Adam, Canada
The role of sex and T cells in natural vs induced ABO antibody production in mice
Ibrahim Adam, Canada
The role of sex and T cells in natural vs induced ABO antibody production in mice
Daniel Luo, Canada
Achieving localized immunosuppression through ex vivo engineering of organ blood vessels
Daniel Luo, Canada
Achieving localized immunosuppression through ex vivo engineering of organ blood vessels
Jordan P Warunek, United States
Recognition of donor MHCI disrupts recipient reparative macrophage differentiation.
Jordan P Warunek, United States
Recognition of donor MHCI disrupts recipient reparative macrophage differentiation.
14:25
- 15:25 		E View Oral Abstracts Session: Kidney - Metabolic challenges in transplantation
Full Details
Manuela B Almeida, Portugal
The impact of donor body mass index on graft survival after living kidney transplantation
Manuela B Almeida, Portugal
The impact of donor body mass index on graft survival after living kidney transplantation
Peter Mannon, United States
The gut microbiome facilitates metabolic syndrome (MBS) post kidney transplantation
Peter Mannon, United States
The gut microbiome facilitates metabolic syndrome (MBS) post kidney transplantation
Anil Chandraker, United States
Dyslipidemia in kidney transplant recipients: Is it time for a change in strategy?
Anil Chandraker, United States
Dyslipidemia in kidney transplant recipients: Is it time for a change in strategy?
Karol Graňák, Slovakia (Slovak Republic)
Regular physical activity in the prevention of post-transplant diabetes mellitus and associated metabolic conditions in kidney transplant recipients
Karol Graňák, Slovakia (Slovak Republic)
Regular physical activity in the prevention of post-transplant diabetes mellitus and associated metabolic conditions in kidney transplant recipients
Samuel Chan, Australia
Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study
Samuel Chan, Australia
Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study
14:25
- 15:25 		F View Mini-Oral Abstracts Session: Vascularized composite allografts and other topics
Full Details
Barbara Kern, Germany
Donor dendritic cell depletion allows novel insights into the alloimmune response following murine composite tissue and skin transplantation
Barbara Kern, Germany
Donor dendritic cell depletion allows novel insights into the alloimmune response following murine composite tissue and skin transplantation
Barbara Kern, Germany
Refinement of hind limb allotransplantation in mice: Introduction of a novel anticoagulation treatment protocol that improves overall success rate
Barbara Kern, Germany
Refinement of hind limb allotransplantation in mice: Introduction of a novel anticoagulation treatment protocol that improves overall success rate
Jeremías Elías Moreira, Argentina
Transplant of the abdominal rectus fascia in rodents, first report of the microsurgical procedure, and initial results
Jeremías Elías Moreira, Argentina
Transplant of the abdominal rectus fascia in rodents, first report of the microsurgical procedure, and initial results
Phil Halloran, Canada
Combining donor derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses
Phil Halloran, Canada
Combining donor derived cell-free DNA fraction and quantity to detect kidney transplant rejection using molecular diagnoses
Justin Rosenheck, United States
Clinical validation of a plasma donor-derived cell-free DNA assay to detect allograft rejection and injury in lung transplant
Justin Rosenheck, United States
Clinical validation of a plasma donor-derived cell-free DNA assay to detect allograft rejection and injury in lung transplant
Max Downey, United States
Patient definitions of transplant “success” of upper extremity VCA
Max Downey, United States
Patient definitions of transplant “success” of upper extremity VCA
Aram Gazarian, France
Total bilateral arm transplantation: functional recovery and psychosocial outcomes at one year
Aram Gazarian, France
Total bilateral arm transplantation: functional recovery and psychosocial outcomes at one year
Meric Yavuz Colak, Turkey
A new era in transplantation: Artificial intelligence, augmented reality, virtual reality and metaverse
Meric Yavuz Colak, Turkey
A new era in transplantation: Artificial intelligence, augmented reality, virtual reality and metaverse
Quan Zhuang Sr., People's Republic of China
Assessment of music intervention on psychological stress and immune function in the early postoperative period of renal allograft recipients: a prospective RCT
Quan Zhuang Sr., People's Republic of China
Assessment of music intervention on psychological stress and immune function in the early postoperative period of renal allograft recipients: a prospective RCT
Andrea García, Colombia
Using artificial intelligence to classify the status of kidney allograft in routine clinical records
Andrea García, Colombia
Using artificial intelligence to classify the status of kidney allograft in routine clinical records

15:25 - 15:55 |  TTS Business Meeting

15:40 - 17:30 |  State-of-the-Art Sessions

15:40
- 16:00 		C3 View Mini-Oral Abstracts Session: Bone Marrow
Full Details
Alejandro M Requejo, Argentina
Chagas disease (CD) after hematopoietic stem cells transplantation (HSCT). Incidence, diagnosis and management
Alejandro M Requejo, Argentina
Chagas disease (CD) after hematopoietic stem cells transplantation (HSCT). Incidence, diagnosis and management
Ana Lisa Basquiera, Argentina
Cryopreserved vs non-Cryopreserved Graft Before Autologous Stem Cell Transplantation in Patients with Multiple Myeloma. A Comparative Study
Ana Lisa Basquiera, Argentina
Cryopreserved vs non-Cryopreserved Graft Before Autologous Stem Cell Transplantation in Patients with Multiple Myeloma. A Comparative Study
Ana Lisa Basquiera, Argentina
Hematopoietic cell transplantation from volunteer unrelated donor between 2016 and 2021: a collaborative study GATMO-TC and INCUCAI
Ana Lisa Basquiera, Argentina
Hematopoietic cell transplantation from volunteer unrelated donor between 2016 and 2021: a collaborative study GATMO-TC and INCUCAI
16:00
- 17:30 		C3 View State-of-the-Art Session: Hematopoietic stem cells transplantation, classical and new indications
Full Details
Maria Carolina O Rodrigues, Brazil
Autologous HSCT in autoimmune diseases (EG: multiple sclerosis)
Maria Carolina O Rodrigues, Brazil
Autologous HSCT in autoimmune diseases (EG: multiple sclerosis)
Damiano Rondelli, United States
Allogeneic HSCT in ALL/AML. The best donor, conditioning, prevention of relapse
Damiano Rondelli, United States
Allogeneic HSCT in ALL/AML. The best donor, conditioning, prevention of relapse
Ephraim J Fuchs, United States
Allo HSCT as inducing immune tolerance to solid organs transplantation
Ephraim J Fuchs, United States
Allo HSCT as inducing immune tolerance to solid organs transplantation
Ibrahim Yakoub-Agha, France
CAR T cells therapy
Ibrahim Yakoub-Agha, France
CAR T cells therapy
16:00
- 17:30 		C1 View State-of-the-Art Session: Vaccines & SOT: immunization saves lives
Full Details
Olivia Smibert, Australia
Challenging cases involving vaccination of transplant recipients (including risks vaccination/mention HLA)
Olivia Smibert, Australia
Challenging cases involving vaccination of transplant recipients (including risks vaccination/mention HLA)
Deepali Kumar, Canada
Moving beyond standard of care to improve vaccine responses
Deepali Kumar, Canada
Moving beyond standard of care to improve vaccine responses
Oriol Manuel, Switzerland
Vaccination: updates and best practices pre- and post- transplant
Oriol Manuel, Switzerland
Vaccination: updates and best practices pre- and post- transplant
16:00
- 17:30 		C2 View State-of-the-Art Session: Latest technologies and advances in the detection of allograft rejection and tissue injury status
Full Details
Carla C. Baan, Netherlands
Liquid biopsy in transplantation: ready for prime time
Carla C. Baan, Netherlands
Liquid biopsy in transplantation: ready for prime time
Jesper Kers, Netherlands
Artificial Intelligence algorithms: from "research use only" to everyday practice?
Jesper Kers, Netherlands
Artificial Intelligence algorithms: from "research use only" to everyday practice?
Ivy A. Rosales, United States
Spatial molecular profiling of kidney allograft biopsies
Ivy A. Rosales, United States
Spatial molecular profiling of kidney allograft biopsies
16:00
- 17:30 		C4 View State-of-the-Art Session: The impact of sex and gender in transplantation
Full Details
Bethany Foster, Canada
Outcomes in transplantation - does sex matter?
Bethany Foster, Canada
Outcomes in transplantation - does sex matter?
Friederike Martin, Germany
The impact of sex hormones on transplant outcomes
Friederike Martin, Germany
The impact of sex hormones on transplant outcomes
Amanda Vinson, Canada
COVID troubles: impact of sex on COVID 19 disease in solid organ transplantation
Amanda Vinson, Canada
COVID troubles: impact of sex on COVID 19 disease in solid organ transplantation
16:00
- 17:30 		C5 View State-of-the-Art Session: Stem cells and advanced organoid technology - Also VCA open discussion
Full Details
Rocky S. Tuan, Hong Kong
Tissue engineering
Rocky S. Tuan, Hong Kong
Tissue engineering
Nuria Montserrat Pulido, Spain
Mini organs: how to advance organoid technology to organ transplant
Nuria Montserrat Pulido, Spain
Mini organs: how to advance organoid technology to organ transplant
Hatem Amer, United States
Current state of VCA and regenerative medicine: what do you think (open discussion)
Hatem Amer, United States
Current state of VCA and regenerative medicine: what do you think (open discussion)
16:00
- 17:30 		D View State-of-the-Art Session: Multidisciplinary approach in transplant oncology - expanding liver transplantation for cancer: call in the multidisciplinary troops
Full Details
Andrea Frilling, United Kingdom
What are the limits for neuroendocrine tumors?
Andrea Frilling, United Kingdom
What are the limits for neuroendocrine tumors?
Gonzalo Sapisochin, Canada
Strategies to minimize the risk of recurrence of cholangiocarcinona (iCCA)
Gonzalo Sapisochin, Canada
Strategies to minimize the risk of recurrence of cholangiocarcinona (iCCA)
Juliet Emamaullee, United States
Cell free DNA in the diagnosis of HCC
Juliet Emamaullee, United States
Cell free DNA in the diagnosis of HCC
16:00
- 17:30 		E View State-of-the-Art Session: Surgical challenges in kidney transplant (adult and pediatric)
Full Details
Jose Otto Reusing Junior, Brazil
Considerations on the prothrombotic patient: prophylaxis and risks
Jose Otto Reusing Junior, Brazil
Considerations on the prothrombotic patient: prophylaxis and risks
Enrico Benedetti, United States
Robotic procedures in the transplanted patients
Enrico Benedetti, United States
Robotic procedures in the transplanted patients
Paulo C. Koch Nogueira, Brazil
Transplanting low-weight children
Paulo C. Koch Nogueira, Brazil
Transplanting low-weight children
16:00
- 17:30 		F View State-of-the-Art Session: COVID-19 era: what has changed for lung transplantation?
Full Details
Sandra Lindstedt MD, PhD, Sweden
Accessibility and indication for lung transplantation in post SARS (covid 19) patients
Sandra Lindstedt MD, PhD, Sweden
Accessibility and indication for lung transplantation in post SARS (covid 19) patients
Pedro Felipe Undurraga, Chile
ECMO and EVLP: prior to and during the pandemic
Pedro Felipe Undurraga, Chile
ECMO and EVLP: prior to and during the pandemic
Massimo Boffini, Italy
Sensitized patients in lung transplantation
Massimo Boffini, Italy
Sensitized patients in lung transplantation

17:40 - 19:00 |  Closing Plenary Session

17:40
- 19:10 		A View Future perspectives in transplantation
Full Details
Dorry Segev, United States
Transplant activity and pandemics: how to apply the lessons learned to patient care and research
Dorry Segev, United States
Transplant activity and pandemics: how to apply the lessons learned to patient care and research
Muhammad M. Mohiuddin, United States
First heart xenotransplantation: a proof of concept for other organs
Muhammad M. Mohiuddin, United States
First heart xenotransplantation: a proof of concept for other organs
Iris V. Rivero, United States
Bio artificial organs for transplantation - how far are we from clinical use?
Iris V. Rivero, United States
Bio artificial organs for transplantation - how far are we from clinical use?
Email: info@tts2022.org
514-874-1717 x203
© 2024 TTS 2022